US Stock MarketDetailed Quotes

DRRX Durect

Watchlist
  • 1.1600
  • +0.1700+17.17%
Close May 3 16:00 ET
  • 1.1500
  • -0.0100-0.86%
Post 17:37 ET
36.00MMarket Cap-966P/E (TTM)

About Durect Company

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Company Profile

SymbolDRRX
Company NameDurect
Listing DateSep 28, 2000
Issue Price12.00
Founded1998
CEOMr. James E. Brown,D.V.M.
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10240 Bubb Road
CityCupertino
ProvinceCalifornia
CountryUnited States of America
Zip Code95014-4166
Phone1-408-777-1417
Websitehttp://www.durect.com

Company Executives

  • Name
  • Position
  • Salary
  • James E. Brown,D.V.M.
  • President, Chief Executive Officer and Director
  • 1.51M
  • Dr. Norman L. Sussman, M.D.
  • Chief Medical Officer
  • 849.68K
  • Timothy M. Papp
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Jian Li
  • Interim Principal Accounting Officer, Senior Vice President, Finance, Corporate Controller and Secretary
  • --
  • Gail J. Maderis, M.B.A.
  • Chairman of the Board
  • 86.15K
  • Dr. Gail M. Farfel, PhD
  • Director
  • 70.65K
  • Peter S. Garcia, M.B.A.
  • Independent Director
  • 72.93K
  • Dr. Mohammad Azab, M.B.,M.D.,M.Sc.
  • Independent Director
  • 81.65K
  • Judith J. Robertson
  • Independent Director
  • 79.94K
  • Terrence F. Blaschke,M.D.
  • Independent Director
  • 83.15K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg